Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On November 16, 2026, NextCure, Inc. (the “Company”, “we”, “us”, or “our”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that we were not in compliance with the minimum stockholders’ equity requirement applicable to companies listed on the Nasdaq Global Select Market under Listing Rule 5450(b)(1)(A) (the “Minimum Stockholders’ Equity Requirement”), because the Company’s stockholders’ equity of $5,503,000, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, was below the required minimum of $10.0 million, and because, as of November 16, 2026, the Company did not meet the alternative compliance standards relating to the market value of the listed securities or the Company’s total assets and revenue.
In accordance with Nasdaq Listing Rule 5810(c)(2)(C), we have 45 calendar days, or until January 4, 2027, to submit a plan to regain compliance with the Minimum Stockholders’ Equity Requirement (the “Grace Period”). The closing of the Company’s previously announced proposed merger (the “Merger”) with Avere Therapeutics, Inc. (“Avere”) is expected to occur in mid-December 2026, subject to stockholder approval and other customary closing conditions, which is before the Grace Period ends. The Company believes that consummation of the Merger prior to the expiration of the Grace Period would result in the Company regaining compliance with the Minimum Stockholders’ Equity Requirement and, therefore, may eliminate the need to submit a compliance plan to Nasdaq. If the Merger is not completed before the Grace Period ends, the Company intends to submit a plan to regain compliance.
The Notice has no immediate effect on the listing or trading of our common stock, which will continue to be listed and traded on the Nasdaq Global Select Market, subject to our compliance with other Nasdaq listing requirements. There can be no assurance that the Company will be able to regain compliance with the Minimum Stockholders’ Equity Requirement or maintain compliance with the other Nasdaq listing requirements.
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning the Company, the Merger, the Minimum Stockholders’ Equity Requirement, and other matters. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “aim”, “anticipate”, “assume”, “believe”, “continue”, “could”, “should”, “due”, “estimate”, “expect”, “intend”, “hope”, “may”, “objective”, “plan”, “predict”, “project”, “potential”, “positioned”, “seek”, “target”, “towards”, “forward”, “later”, “will”, “would”, and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or similar language.
Forward-looking statements involve substantial risks and uncertainties that could cause actual results to differ materially from those projected in any forward-looking statement. Such risks and uncertainties include, among others: risks associated with the possible failure to satisfy the conditions to the closing or consummation of the Merger, including the Company’s failure to obtain stockholder approval for the Merger, risks associated with the potential failure to complete the financing transaction in a timely manner or at all, risks associated with the uncertainty as to the timing of the consummation of the Merger and the ability of each of the Company and Avere to consummate the transactions contemplated by the Merger, risks associated with the Company’s continued listing on Nasdaq until closing of the Merger, the failure or delay in obtaining required approvals from any governmental or quasi-governmental entity necessary to consummate the Merger, the occurrence of any event, change, or other circumstance or condition that could give rise to the termination of the Merger prior to the closing or consummation of the Merger, the Company’s ability to regain or maintain compliance with the Minimum Stockholders’ Equity Requirement and other Nasdaq continued listing requirements, and market and other conditions.
More detailed information on these and additional factors that could affect the Company’s actual results are described under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K, its subsequent Quarterly Reports on Form 10-Q and the Company’s other filings with the SEC. You should not place undue reliance on any forward-looking statements. Forward-looking statements speak only as of the date of this Current Report on Form 8-K, and the Company assumes no obligation to update any forward-looking statements, even if expectations change.